MariMed Inc. (MRMD) Financial Statements (2024 and earlier)

Company Profile

Business Address 10 OCEANA WAY
NORWOOD, MA 02062
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,73721,6999,86011,3878,43634,720
Cash and cash equivalents14,63521,5959,73711,1137,91133,467
Short-term investments1021041232745251,253
Receivables8,1867,0226,8236,8285,5613,720
Inventory, net of allowances, customer advances and progress billings24,78622,72319,47718,30915,88912,238
Inventory24,78622,72319,47718,30915,88912,238
Other current assets9,5417,2447,2823,7683,0592,179
Other undisclosed current assets6676867045916051,457
Total current assets:57,91759,37444,14640,88333,55054,314
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization2,263871713747541576
Operating lease, right-of-use asset9,89810,1224,9314,9545,0714,913
Property, plant and equipment78,63473,71471,64170,39669,13265,482
Long-term investments and receivables8,5467,5237,4679,1609,1169,204
Long-term investments89    100
Accounts and financing receivable, after allowance for credit loss8,4577,5237,4679,1609,1169,104
Intangible assets, net (including goodwill)30,69331,48422,28017,54817,9772,395
Goodwill11,99312,0048,0798,0798,079 
Intangible assets, net (excluding goodwill)18,70019,48014,2019,4699,8982,395
Other noncurrent assets1,4171,3031,0241,01049198
Total noncurrent assets:131,451125,017108,056103,815102,32882,668
TOTAL ASSETS:189,368184,391152,202144,698135,878136,982
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,3807,6339,71722,90121,09831,453
Taxes payable11,66310,00121,414
Accounts payable7,7644,6656,6267,9737,6248,311
Accrued liabilities3,6162,9683,0913,2653,4731,728
Debt4,3523,6224,011241180188
Other undisclosed current liabilities13,49313,25412,7624,1093,9352,544
Total current liabilities:29,22524,50926,49027,25125,21334,185
Noncurrent Liabilities
Long-term debt and lease obligation22,06221,34126,4044,6974,7584,761
Long-term debt, excluding current maturities20,54620,80325,943  46
Finance lease, liability1,516538461483338372
Liabilities, other than long-term debt8,7318,9374,273100100100
Other liabilities100100100100100100
Operating lease, liability8,6318,8374,1734,2144,4204,343
Other undisclosed noncurrent liabilities26,54426,610 23,04820,62916,624
Total noncurrent liabilities:57,33756,88830,67727,84525,48721,485
Total liabilities:86,56281,39757,16755,09650,70055,670
Temporary equity, carrying amount21,90237,72537,72537,72537,72537,725
Equity
Equity, attributable to parent82,49766,83358,78253,35748,90945,196
Common stock372348341339339336
Common stock, value, subscriptions  2 41  
Additional paid in capital167,652151,052142,365141,652139,951138,064
Accumulated deficit(85,527)(84,569)(83,924)(88,675)(91,381)(93,204)
Equity, attributable to noncontrolling interest(1,593)(1,564)(1,511)(1,480)(1,456)(1,611)
Other undisclosed equity   39  2
Total equity:80,90465,26957,31051,87747,45343,587
TOTAL LIABILITIES AND EQUITY:189,368184,391152,202144,698135,878136,982

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues36,51934,38035,83033,91232,98631,282
Operating lease, lease income4004001,226400 19,900
Cost of revenue(20,143)(18,992)(20,018)(17,748)(17,981)(14,306)
Gross profit:16,37615,38815,81216,16415,00516,976
Operating expenses(12,829)(10,253)(12,723)(10,428)(10,510)(9,927)
Operating income:3,5475,1353,0895,7364,4957,049
Nonoperating income (expense)(2,535)(3,306)(334)(530)(849)852
Other nonoperating income (expense)(10)(900)(151)(251)(727)954
Interest and debt expense(2,640)(2,505)(422)(518)(440)(313)
Income (loss) from continuing operations before equity method investments, income taxes:(1,628)(676)2,3334,6883,2067,588
Other undisclosed income from continuing operations before income taxes2,6402,505422518440313
Income from continuing operations before income taxes:1,0121,8292,7555,2063,6467,901
Income tax expense (benefit)(1,947)(2,493)2,000(2,484)(1,750)(3,660)
Income (loss) from continuing operations:(935)(664)4,7552,7221,8964,241
Income before gain (loss) on sale of properties:2,7221,8964,241
Net income (loss):(935)(664)4,7552,7221,8964,241
Net income (loss) attributable to noncontrolling interest(23)19(4)(16)(73)(53)
Net income (loss) available to common stockholders, diluted:(958)(645)4,7512,7061,8234,188

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(935)(664)4,7552,7221,8964,241
Comprehensive income (loss):(935)(664)4,7552,7221,8964,241
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(23)19(4)(16)(73)(53)
Comprehensive income (loss), net of tax, attributable to parent:(958)(645)4,7512,7061,8234,188

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: